Vienna - Delayed Quote EUR

Valneva SE (VLA.VI)

2.8640
+0.0380
+(1.34%)
At close: May 9 at 4:48:17 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
169,578
169,578
153,712
361,303
348,085
Cost of Revenue
98,538
98,538
100,875
324,441
187,920
Gross Profit
71,040
71,040
52,837
36,862
160,165
Operating Expense
148,809
148,809
134,949
150,305
221,514
Operating Income
-77,769
-77,769
-82,112
-113,443
-61,349
Net Non Operating Interest Income Expense
-21,622
-21,622
-22,115
-18,794
-16,714
Other Income Expense
87,906
87,906
5,598
-12,578
8,083
Pretax Income
-11,486
-11,486
-98,629
-144,815
-69,979
Tax Provision
761
761
2,800
-1,536
3,446
Net Income Common Stockholders
-12,247
-12,247
-101,429
-143,279
-73,425
Diluted NI Available to Com Stockholders
-12,247
-12,247
-101,429
-143,279
-73,425
Basic EPS
-0.08
-0.08
-0.73
-1.24
-0.75
Diluted EPS
-0.08
-0.08
-0.73
-1.24
-0.75
Basic Average Shares
145,705.8760
145,705.8760
138,943.8360
115,473.9140
97,619.3200
Diluted Average Shares
145,705.8760
145,705.8760
138,943.8360
115,473.9140
97,619.3200
Total Operating Income as Reported
13,330
13,330
-82,087
-113,443
-61,390
Total Expenses
247,347
247,347
235,824
474,746
409,434
Net Income from Continuing & Discontinued Operation
-12,247
-12,247
-101,429
-143,279
-73,425
Normalized Income
-10,051.7500
-10,051.7500
-105,627.5000
-130,825.5057
-79,369.6800
Interest Income
2,362
2,362
1,210
260
249
Interest Expense
23,984
23,984
23,325
19,054
16,963
Net Interest Income
-21,622
-21,622
-22,115
-18,794
-16,714
EBIT
12,498
12,498
-75,304
-125,761
-53,016
EBITDA
32,084
32,084
-57,720
-104,725
-38,735
Reconciled Cost of Revenue
98,538
98,538
100,875
324,441
187,920
Reconciled Depreciation
19,586
19,586
17,584
21,036
14,281
Net Income from Continuing Operation Net Minority Interest
-12,247
-12,247
-101,429
-143,279
-73,425
Total Unusual Items Excluding Goodwill
-2,927
-2,927
5,598
-12,587
8,088
Total Unusual Items
-2,927
-2,927
5,598
-12,587
8,088
Normalized EBITDA
35,011
35,011
-63,318
-92,138
-46,823
Tax Rate for Calcs
0.0003
0.0003
0.0003
0
0.0003
Tax Effect of Unusual Items
-731.7500
-731.7500
1,399.5000
-133.5057
2,143.3200
12/31/2021 - 9/8/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABVX.PA ABIVAX Société Anonyme
6.17
-1.28%
 
RLF.SW Relief Therapeutics Holding SA
2.1600
-0.92%
 
IFRX InflaRx N.V.
1.6100
+1.90%
 
ACIU AC Immune SA
1.6800
+1.20%
 
PCVX Vaxcyte, Inc.
31.16
-0.92%
 
LXRX Lexicon Pharmaceuticals, Inc.
0.7010
+1.73%
 
QURE uniQure N.V.
12.79
+4.41%
 
ARGX argenx SE
549.65
-3.42%
 
OCGN Ocugen, Inc.
0.6700
-2.81%
 
TNXP Tonix Pharmaceuticals Holding Corp.
18.83
-0.58%